ALKERMES reported 313.8M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Acadia Pharmaceuticals ACAD:US $ 158.93M 14.4M
Acorda Therapeutics ACOR:US $ 47.47M 10.17M
Amgen AMGN:US $ 5.7B 1.93B
Biogen BIIB:US $ 1984.9M 304.4M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bluebird Bio BLUE:US $ 248.31M 4.31M
Bristol Myers Squibb BMY:US $ 9.63B 360M
Coherus Biosciences CHRS:US $ 111.81M 138.59M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Gilead Sciences GILD:US $ 3971M 438M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
H. Lundbeck A/S LUN:DC 3.36B 27M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Horizon Pharma HZNP:US $ 694.03M 191.61M
Intra Cellular Therapies ITCI:US $ 89.19M 20.09M
IONIS PHARMACEUT IONS:US $ 207.35M 3.77M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Marinus Pharmaceuticals MRNS:US $ 25.39M 3.58M
Merk MRK:US $ 9788M 722M
Minerva Neurosciences NERV:US $ 8.96M 1.46M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Otsuka Holdings 4578:JP Y 320950M 34253M
Pfizer PFE:US $ 13063M 3998M
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Revance Therapeutics RVNC:US $ 89.14M 5.83M
Teva Pharmaceutical Industries TEVA:US 3.26B 64M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
Zogenix ZGNX:US $ 74.22M 8.73M